Madrigal Pharmaceuticalsの空売り状況は、投資家がMadrigal Pharmaceuticalsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Madrigal Pharmaceuticals (NASDAQ:MDGL) 株価情報, 空売り情報

Madrigal Pharmaceuticals

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.

Madrigal Pharmaceuticals, Inc. - Common Stock

Madrigal Pharmaceuticals Inc

The <a href="https://www.benzinga.com/topic/drug-enforcement-administration">Drug Enforcement Administration</a> (DEA) has denied accusations of improper communication with cannabis prohibitionist group Smart Approaches to Marijuana (SAM) during the Biden administration's <a href="https://www.benzinga.com/topic/cannabis-rescheduling">marijuana rescheduling process</a>.
In a recent filing <a href="https://www.marijuanamoment.net/dea-says-it-didnt-conspire-with-anti-marijuana-group-dismissing-allegedly-illegal-talks-as-gossip/">reported</a> by Marijuana Moment, the agency dismissed these allegations as "gossip." While the DEA admitted to the communication, it argued they were no unlawful ex parte and that no harm was done and therefore, the motion by<a href="https://www.benzinga.com/markets/cannabis/24/11/41726679/village-farms-is-only-cannabis-operator-selected-to-represent-weed-industry-at-dea-rescheduling-"> Village Farms International</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) and Hemp for Victory should be dismissed.
<h3 class="wp-block-heading">Allegations Of Misconduct</h3>
Part of the accusations stem from social media posts by SAM president and CEO Kevin Sabet.
In a post May 6, 2024 on X, Sabet admitted to having conversations with &#8220;two confidential sources inside DEA.&#8221; Sabet said these discussions provided inside information about the agency's stance on marijuana rescheduling, including a claim that DEA Administrator Anne Milgram would not approve a proposed rule.
This post was presented as evidence by <a href="https://www.benzinga.com/cannabis">cannabis</a> advocacy groups to support their broader claim that <a href="https://www.benzinga.com/topic/dea-cannabis">the DEA</a> holds a contradictory position, alleging the agency is acting as both judge and participant in the cannabis rescheduling process.
The post by Sabet admitting to the conversations with insider sources is still on X. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">BIG: I can now say with full confidence that the Administrator of DEA, Anne Milgram, did NOT sign the rescheduling order, breaking with five decades of precedent and established law and regulations (two confidential sources inside DEA and another outside DEA with intimate…
&mdash; Kevin Sabet (@KevinSabet) <a href="https://twitter.com/KevinSabet/status/1787569052782846142?ref_src=twsrc%5Etfw">May 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Also: <a href="https://www.benzinga.com/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens">DEA Slammed For Unlawful Talks With Cannabis Opponents &#8211; The Plot Thickens</a>
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
<h3 class="wp-block-heading">DEA's Defense</h3>
According to the DEA's filing, the cannabis organizations' evidence is not proof of <a href="https://www.benzinga.com/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens">misconduct</a>. &#8220;Movants' own evidence fails to demonstrate that any unlawful ex parte communication took place," the agency said. A movant is any party that makes a motion in a case.
The DEA flatly rejected accusations of bias or impropriety, emphasizing that the submitted evidence amounts to little more than hearsay. 
"The Movants would have this tribunal embark on a fishing expedition in search of evidence to support these sweeping, unsupported claims, which at best can be categorized as gossip, not ex parte communications," the DEA stated.
It also dismissed calls for the <a href="https://www.benzinga.com/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens">agency's removal </a>from the rescheduling process, arguing that there is no legal precedent for such action. 
"The only authority cited by the Movants on this point simply supports the notion that specific individuals may be removed from the proceeding under the appropriate circumstances," per the filing.
Additionally, the DEA pointed out that no misconduct has been alleged against its attorneys involved in the proceedings, further undermining the motion's validity.
As a consequence, the DEA requested the motion's dismissal. "The tribunal correctly questions the seriousness of the remedies sought by the Movants and as such, should deny the motion," the agency concluded. 
Village Farms International is <a href="https://www.benzinga.com/markets/cannabis/24/11/41726679/village-farms-is-only-cannabis-operator-selected-to-represent-weed-industry-at-dea-rescheduling-">the only cannabis operator</a> selected to represent the industry at the<a href="https://www.benzinga.com/markets/cannabis/24/11/41726679/village-farms-is-only-cannabis-operator-selected-to-represent-weed-industry-at-dea-rescheduling-"> </a>upcoming hearing on December 2. 
<ul>
<li>Read Next: <a href="https://www.benzinga.com/24/11/42169153/dea-judge-blocks-researchers-motion-in-cannabis-rescheduling-case">DEA Judge Blocks Researcher&#8217;s Motion In Cannabis Rescheduling Case</a></li>
</ul>
Cover: AI generated image

Cannabis

Government

News

Regulations

Politics

Legal

Markets

DEA Denies Allegations Of Colluding With Anti-Marijuana Group While Involved In Cannabis Rescheduling Process

WIIM

ALLY

Ally Financial shares are trading higher after last week's report suggesting the company is assessing the potential sale of its credit card business.

ONEOK shares are trading lower after the company announced plans to acquire the remaining EnLink units in a $4.3 billion stock deal.

Shares of Zoom Video Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) are trading higher Monday. The company is set to release earnings results after the market close. Here&#8217;s what <a href="https://www.benzinga.com/quote/ZM/earnings">you need to know.</a>
What To Know: Zoom Video is due to report third-quarter financial results for fiscal 2025 after the bell. Analysts expect the company to report earnings of $1.31 per share for the quarter, up from $1.29 per share a year ago. Revenue is projected at $1.16 billion, compared to $1.14 billion in the same period last year, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
In the company&#8217;s most-recent quarter, Zoom reported earnings of $1.39 per share, beating the estimate of $1.21 by 14.88%. Revenue came in at $1.16 billion, exceeding expectations and reflecting a 2.09% increase year-over-year.
"In Q2, we outperformed our guidance across the board and grew operating cash flow and free cash flow by 33.7% and 26.2% year over year, respectively, demonstrating our continued commitment to efficient growth," Zoom CEO Eric Yuan said last quarter.
"We also saw strength in large accounts, with customers contributing more than $100,000 in trailing 12 months revenue increasing by 7.1% year over year, and resilience in our Online business, with Online average monthly churn reaching its lowest ever rate.&#8221;
Zoom Video shares have gained nearly 24% since the company last reported earnings. The stock is currently trading at new 52-week highs ahead of earnings. Zoom Video has a 52-week low of $55.06, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. 
Multiple analysts have weighed in on Zoom shares in recent weeks leading up to earnings. Rosenblatt analyst Catharine Trebnick maintained Zoom with a <a href="https://www.benzinga.com/analyst-stock-ratings">Buy rating</a> and price target of $78. Morgan Stanley analyst Meta Marshall maintained an Equal-Weight rating and raised the price target from $68 to $86.
ZM Price Action: Zoom shares were up 3.57% at $88.96 at the time of publication, according to<a href="https://pro.benzinga.com/dashboard"> Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="540" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25141156/Zm-1024x540.png" alt="" class="wp-image-664052" style="width:454px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25141156/Zm-1024x540.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25141156/Zm-300x158.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25141156/Zm-768x405.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25141156/Zm.png 1450w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/gaming/24/11/42172580/black-playstation-accessories-may-appear-ahead-of-holiday-season-dealabs">Black PlayStation Accessories May Appear Ahead Of Holiday Season: Dealabs</a></li>
</ul>
Image via Unsplash.

Earnings

Previews

Movers

What's Going On With Zoom Video Stock Today?

Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) recent rally could face a sharp downturn, with a prominent trader warning of a potential correction if the cryptocurrency fails to break the <a href="https://www.benzinga.com/news/small-cap/24/11/42171130/russell-2000-dow-sp-500-all-achieve-record-highs-in-wall-streets-historic-day-bitcoin-gold-tumble-whats-driving-markets-monday">$100,000 resistance level.</a>
The <a href="https://x.com/ali_charts/status/1860409141677662707">forecast</a>, which points to a drop as low as $85,600 in a worst-case scenario, comes as Bitcoin shows signs of a cooling rally after nearing the critical $100,000 milestone. 
On Nov. 23, chart analyst Ali Martinez <a href="https://x.com/ali_charts/status/1860409141677662707">flagged</a> a bearish signal on Bitcoin's 12-hour chart using the TD Sequential indicator.
Ali predicted that Bitcoin could correct to $91,583, with a deeper drop to $85,610 if selling pressure intensifies.
The apex crypto is trading around $94,660 at the time of writing, down 1.6% over the past 24 hours.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42171439/solana-meme-coin-platform-pumpfun-faces-backlash-over-scandalous-livestreams-but-polymarket-traders-arent-convinced-theyll-go-dark">Solana Meme Coin Platform Pump.Fun Faces Backlash Over Scandalous Livestreams, But Polymarket Traders Aren&#8217;t Convinced They&#8217;ll Go Dark</a>
Altcoins such as Ripple (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) and Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) are down over 5%, while Solana's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>), Ether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), Cardano's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>) and Binance's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bnb/usd">BNB</a>) fell between 2% and 5%.
This market-wide retreat caused the overall crypto market capitalization to decline by 2.4%.
The volatility also hit crypto-tracked futures, with over $400 million liquidated in both long and short positions.
According to Coinglass <a href="https://www.coinglass.com/LiquidationData">data</a>, $283 million in bullish bets and $156 million in bearish bets were wiped out over the past 24 hours. 
Interestingly, small altcoins and midcap futures saw higher liquidation volumes than Bitcoin and Ether, suggesting increased risk-taking among traders.
The market correction comes against the backdrop of deteriorating sentiment in the cryptocurrency industry as Bitcoin failed to break <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42163156/why-bitcoins-rally-is-stalling-below-100000">the $100,000 threshold</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42170669/wisdomtree-files-for-xrp-etf-trust-report">WisdomTree Files For XRP ETF Trust: Report</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ADA

$BNB

$BTC

$DOGE

$ETH

$SOL

$XRP

Bitcoin Slides Below $95,000 — Analyst Predicts Potential Correction To $85,000

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Hims & Hers Health shares are trading higher. Strength has been attributed to President-elect Donald Trump's plans to nominate Marty Makary to lead the FDA.

Investors with a lot of money to spend have taken a bearish stance on Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with UBER, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 39 uncommon options trades for Uber Technologies.
This isn't normal.
The overall sentiment of these big-money traders is split between 41% bullish and 53%, bearish.
Out of all of the special options we uncovered, 5 are puts, for a total amount of $316,232, and 34 are calls, for a total amount of $2,204,315.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $50.0 to $100.0 for Uber Technologies during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Uber Technologies's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Uber Technologies's whale trades within a strike price range from $50.0 to $100.0 in the last 30 days. 
<h3>Uber Technologies Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732563026_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$10.95</td>
<td>$10.85</td>
<td>$10.87</td>
<td>$95.00</td>
<td>$243.8K</td>
<td>635</td>
<td>1.0K</td>
</tr>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$12.6</td>
<td>$12.3</td>
<td>$12.3</td>
<td>$75.00</td>
<td>$228.9K</td>
<td>3.1K</td>
<td>265</td>
</tr>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$16.05</td>
<td>$14.65</td>
<td>$15.69</td>
<td>$80.00</td>
<td>$156.9K</td>
<td>343</td>
<td>101</td>
</tr>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$15.7</td>
<td>$15.4</td>
<td>$15.64</td>
<td>$80.00</td>
<td>$156.4K</td>
<td>343</td>
<td>301</td>
</tr>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$15.95</td>
<td>$15.4</td>
<td>$15.63</td>
<td>$80.00</td>
<td>$156.3K</td>
<td>343</td>
<td>201</td>
</tr>
</tbody>
</table>

<h3>About Uber Technologies</h3>
Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food delivery service providers, and shippers with carriers. The firm's on-demand technology platform could eventually be used for additional products and services, such as autonomous vehicles, delivery via drones, and Uber Elevate, which, as the firm refers to it, provides "aerial ride-sharing." Uber Technologies is headquartered in San Francisco and operates in over 63 countries with over 150 million users who order rides or food at least once a month.
<h3>Current Position of Uber Technologies</h3>
<ul>
<li>With a volume of 8,625,720, the price of UBER is up 2.51% at $73.31. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 72 days.</li>
</ul>
<h3>What The Experts Say On Uber Technologies</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $93.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Uber Technologies with a target price of $90. 
&#x2A; An analyst from Loop Capital has decided to maintain their Buy rating on Uber Technologies, which currently sits at a price target of $86. 
&#x2A; An analyst from Keybanc has decided to maintain their Overweight rating on Uber Technologies, which currently sits at a price target of $85. 
&#x2A; Maintaining their stance, an analyst from Evercore ISI Group continues to hold a Outperform rating for Uber Technologies, targeting a price of $120. 
&#x2A; An analyst from Gordon Haskett upgraded its action to Buy with a price target of $85. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Uber Technologies, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

UBER

Market Whales and Their Recent Bets on UBER Options

Investors with a lot of money to spend have taken a bullish stance on Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NEM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 10 uncommon options trades for Newmont.
This isn't normal.
The overall sentiment of these big-money traders is split between 70% bullish and 20%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $203,670, and 6 are calls, for a total amount of $800,199.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $30.0 and $60.0 for Newmont, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Newmont options trades today is 3564.38 with a total volume of 5,631.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Newmont's big money trades within a strike price range of $30.0 to $60.0 over the last 30 days.
<h3>Newmont Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732563021_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$3.25</td>
<td>$3.15</td>
<td>$3.24</td>
<td>$45.00</td>
<td>$324.0K</td>
<td>1.3K</td>
<td>1.0K</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$7.5</td>
<td>$7.35</td>
<td>$7.5</td>
<td>$40.00</td>
<td>$269.9K</td>
<td>4.4K</td>
<td>440</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.8</td>
<td>$1.75</td>
<td>$1.8</td>
<td>$42.50</td>
<td>$90.0K</td>
<td>15.2K</td>
<td>944</td>
</tr>
<tr>
<td>NEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$1.1</td>
<td>$0.92</td>
<td>$1.1</td>
<td>$37.50</td>
<td>$84.7K</td>
<td>5.5K</td>
<td>772</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$11.1</td>
<td>$9.9</td>
<td>$11.05</td>
<td>$37.50</td>
<td>$56.1K</td>
<td>130</td>
<td>51</td>
</tr>
</tbody>
</table>

<h3>About Newmont</h3>
Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to produce roughly 5.5 million ounces of gold in 2024 from its core mines and 6.8 million in total. It is likely to sell a number of its higher cost, smaller mines accounting for 20% of forecast sales in 2024. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves along with significant byproduct reserves at the end of December 2023.
<h3>Where Is Newmont Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 5,909,976, with NEM's price down by -2.87%, positioned at $42.13.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 87 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Newmont with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Newmont's Options Frenzy: What You Need to Know

Financial giants have made a conspicuous bearish move on Alnylam Pharmaceuticals. Our analysis of options history for Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) revealed 19 unusual trades.
Delving into the details, we found 5% of traders were bullish, while 84% showed bearish tendencies. Out of all the trades we spotted, 14 were puts, with a value of $931,387, and 5 were calls, valued at $321,410.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $220.0 and $280.0 for Alnylam Pharmaceuticals, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Alnylam Pharmaceuticals stands at 355.17, with a total volume reaching 1,362.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Alnylam Pharmaceuticals, situated within the strike price corridor from $220.0 to $280.0, throughout the last 30 days.
<h3>Alnylam Pharmaceuticals 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732563016_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ALNY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$38.0</td>
<td>$35.6</td>
<td>$38.0</td>
<td>$220.00</td>
<td>$190.0K</td>
<td align="right">262</td>
<td align="right">50</td>
</tr>
<tr>
<td>ALNY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$20.9</td>
<td>$18.5</td>
<td>$19.0</td>
<td>$270.00</td>
<td>$127.3K</td>
<td align="right">601</td>
<td align="right">250</td>
</tr>
<tr>
<td>ALNY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$28.0</td>
<td>$26.9</td>
<td>$28.0</td>
<td>$280.00</td>
<td>$120.4K</td>
<td align="right">312</td>
<td align="right">250</td>
</tr>
<tr>
<td>ALNY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$28.3</td>
<td>$25.2</td>
<td>$28.3</td>
<td>$280.00</td>
<td>$107.5K</td>
<td align="right">312</td>
<td align="right">250</td>
</tr>
<tr>
<td>ALNY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$27.5</td>
<td>$27.4</td>
<td>$27.5</td>
<td>$280.00</td>
<td>$82.5K</td>
<td align="right">312</td>
<td align="right">250</td>
</tr>
</tbody>
</table>

<h3>About Alnylam Pharmaceuticals</h3>
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
After a thorough review of the options trading surrounding Alnylam Pharmaceuticals, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Alnylam Pharmaceuticals</h3>
<ul>
<li>With a volume of 460,809, the price of ALNY is up 3.96% at $254.59. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 80 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Alnylam Pharmaceuticals, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

ALNY

Check Out What Whales Are Doing With ALNY

The Benzinga Future of Digital Assets event featured a panel on NFTs and the metaverse, sparking discussions about their long-term potential despite current skepticism. Post panel, <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42138947/bitcoin-zeroes-in-on-100000-but-this-indicator-signals-one-more-brief-correction">Ian Horne, head of content </a>for Money20/20 Amsterdam, shared his perspective on how these technologies may evolve and gain broader acceptance over time.
<h1 class="wp-block-heading">Moving Beyond Skepticism</h1>
Horne acknowledged the criticism NFTs and the metaverse have faced in recent years, often due to unrealistic expectations and failed projects. But, he argued that their core concepts remain relevant for the future of digital interaction.
"These concepts have been derided rightly for failures in recent years," Horne said, "but long term, the idea of a metaverse becoming a thriving idea, and NFTs being important to identity and how we relate to others online, is completely still valid."
The panel conversation, which included Alex Salnikov of Rarible, delved into how practical applications of NFTs and metaverse technology could reshape online experiences. Horne emphasized that discussing these ideas in a grounded way helps audiences better understand their potential.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42138947/bitcoin-zeroes-in-on-100000-but-this-indicator-signals-one-more-brief-correction">Bitcoin Zeroes In On $100,000, But This Indicator Signals One More Brief Correction</a>
<h1 class="wp-block-heading">Adoption Through Integration</h1>
Addressing skepticism, Horne explained that widespread adoption of these technologies would likely happen when seamlessly integrated into daily activities without being labeled as NFTs or metaverse applications. 
"I think the real adoption of these things is going to happen when we don't talk about it like it being the metaverse or like it being an NFT," he said. Instead, users will engage with digital tools like tokens or online marketplaces without understanding the underlying technology.
Horne stressed the focus should shift to the value these technologies add rather than their technical definitions. "When we're talking about the value add and not the technology, that's when I think we're nailing it," he added.
The panel discussion at the event reflected a broader sentiment that while challenges remain, the long-term promise of NFTs and the metaverse lies in their ability to integrate seamlessly into the digital world and shape how individuals interact online.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42138209/microstrategy-trading-at-insane-256-premium-to-bitcoin-holdings-research-shows">MicroStrategy Trading At &#8216;Insane&#8217; 256% Premium To Bitcoin Holdings, Research Shows</a></li>
</ul>
Photo by Corynn Egreczky.

Events

Exclusives

Interview

NFTs, Metaverse 'Derided Rightly,' But Experts See Bright Future Ahead

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 400 points on Monday.
The Dow traded up 0.95% to 44,718.05 while the NASDAQ rose 0.25% to 19,050.84. The S&amp;P 500 also rose, gaining, 0.29% to 5,986.39.
Check This Out: <a href="https://www.benzinga.com/24/11/42137942/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin">Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin</a>
Leading and Lagging Sectors Consumer discretionary shares jumped by 1.6% on Monday.
In trading on Monday, energy shares fell by 1.8%.
Top Headline
The Dallas Fed&#8217;s Texas manufacturing activity index rose to -2.7 in November compared to a reading of -3 in the previous month and versus market estimates of -2.4.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>BridgeBio Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIO#NASDAQ">BBIO</a>) shares shot up 19% to $27.80 after the company announced that the FDA approved Attruby to treat adults with ATTR-CM.</li>
<li>Shares of Quantum Computing Inc. &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) got a boost, surging 12% to $6.80 after AWS announced Quantum Embark program.</li>
<li>Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) shares were also up, gaining 56% to $2.7211 after the company completed a $100 million at-the-market equity offering, with plans to use the proceeds for working capital, capital expenditures, and advancements in superconducting quantum computing technology.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Cassava Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) shares dropped 81% to $4.7301 after the company announced Simufilam did not show a significant reduction in cognitive or functional decline versus placebo in patients with mild-to-moderate Alzheimer&#8217;s disease in the ReThink-ALZ Phase 3 study.</li>
<li>Shares of Oncternal Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCT#NASDAQ">ONCT</a>) were down 46% to $0.6201 after the company announced that NASDAQ plans to delist its stock.</li>
<li>CareMax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMAX#NASDAQ">CMAX</a>) was down, falling 14% to $0.6205 after the company announced restructuring amidst its bankruptcy and delisting challenges.</li>
</ul>
Commodities In commodity news, oil traded down 3.3% to $68.92 while gold traded down 3.4% at $2,621.10.
Silver traded down 3.4% to $30.265 on Monday, while copper rose 0.2% to $4.0925.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.06%, Germany's DAX gained 0.43% and France's CAC 40 rose 0.03%. Spain's IBEX 35 Index rose 0.47%, while London's FTSE 100 gained 0.36%.
The Ifo Business Climate indicator for Germany fell to 85.7 in November compared to 86.5 in October and down from market expectations of 86. Producer prices in Spain fell by 3.9% year-over-year in October.
Asia Pacific Markets
Asian markets closed mixed on Monday, with Japan's Nikkei 225 gaining 1.30%, Hong Kong's Hang Seng Index falling 0.41%, China's Shanghai Composite Index falling 0.11% and India's BSE Sensex gaining 1.25%.
Economics
<ul>
<li>The Chicago Fed National Activity Index fell to -0.40 in October compared to -0.27 in the previous month and versus market estimates of -0.20.</li>
<li>The Dallas Fed&#8217;s Texas manufacturing activity index rose to -2.7 in November compared to a reading of -3 in the previous month and versus market estimates of -2.4.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42163921/top-3-real-estate-stocks-that-may-explode-in-q4">Top 3 Real Estate Stocks That May Explode In Q4</a></li>
</ul>

Equities

Eurozone

Commodities

Intraday Update

Trading Ideas

BBIO

CMAX

ONCT

QUBT

RGTI

SAVA

Gold Down Over 3%; Rigetti Computing Shares Spike Higher

<a href="https://www.wsj.com/business/media/nbc-ready-to-pay-triple-to-gobble-up-thanksgiving-parade-broadcast-rights-e18fd95f?mod=latest_headlines" title="https://www.wsj.com/business/media/nbc-ready-to-pay-triple-to-gobble-up-thanksgiving-parade-broadcast-rights-e18fd95f?mod=latest_headlines">https://www.wsj.com/business/media/nbc-ready-to-pay-triple-to-gobble-up-thanksgiving-parade-broadcast-rights-e18fd95f?mod=latest_headlines</a>

CMCSA

'NBC, Macy's Near Pact That Would Triple Fees For Broadcasting Thanksgiving Parade; Macy's Parade's Average Annual Fee Would Increase To $60 Million Under New Terms' - WSJ

Whales with a lot of money to spend have taken a noticeably bearish stance on Atlassian.
Looking at options history for Atlassian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) we detected 14 trades.
If we consider the specifics of each trade, it is accurate to state that 42% of the investors opened trades with bullish expectations and 57% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $79,670 and 12, calls, for a total amount of $594,685.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $200.0 and $320.0 for Atlassian, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Atlassian stands at 418.9, with a total volume reaching 4,121.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Atlassian, situated within the strike price corridor from $200.0 to $320.0, throughout the last 30 days.
<h3>Atlassian Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732562141_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TEAM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$21.9</td>
<td>$21.2</td>
<td>$21.4</td>
<td>$280.00</td>
<td>$89.8K</td>
<td align="right">639</td>
<td align="right">45</td>
</tr>
<tr>
<td>TEAM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$31.8</td>
<td>$28.9</td>
<td>$31.8</td>
<td>$260.00</td>
<td>$79.5K</td>
<td align="right">239</td>
<td align="right">25</td>
</tr>
<tr>
<td>TEAM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$18.4</td>
<td>$17.6</td>
<td>$18.2</td>
<td>$290.00</td>
<td>$76.4K</td>
<td align="right">458</td>
<td align="right">45</td>
</tr>
<tr>
<td>TEAM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$72.1</td>
<td>$71.0</td>
<td>$71.0</td>
<td>$200.00</td>
<td>$71.0K</td>
<td align="right">563</td>
<td align="right">10</td>
</tr>
<tr>
<td>TEAM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/13/24</td>
<td>$7.0</td>
<td>$6.5</td>
<td>$7.0</td>
<td>$262.50</td>
<td>$52.5K</td>
<td align="right">0</td>
<td align="right">75</td>
</tr>
</tbody>
</table>

<h3>About Atlassian</h3>
Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Following our analysis of the options activities associated with Atlassian, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Atlassian</h3>
<ul>
<li>With a volume of 1,457,643, the price of TEAM is up 0.7% at $262.4. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 66 days.</li>
</ul>
<h3>What Analysts Are Saying About Atlassian</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $253.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Jefferies persists with their Buy rating on Atlassian, maintaining a target price of $300. 
&#x2A; Showing optimism, an analyst from Keybanc upgrades its rating to Overweight with a revised price target of $260. 
&#x2A; Consistent in their evaluation, an analyst from BMO Capital keeps a Market Perform rating on Atlassian with a target price of $255. 
&#x2A; Consistent in their evaluation, an analyst from Raymond James keeps a Outperform rating on Atlassian with a target price of $250. 
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Hold rating on Atlassian with a target price of $200. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Atlassian, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

TEAM

Atlassian's Options: A Look at What the Big Money is Thinking

High-rolling investors have positioned themselves bullish on Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in ANET often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 19 options trades for Arista Networks. This is not a typical pattern.
The sentiment among these major traders is split, with 42% bullish and 31% bearish. Among all the options we identified, there was one put, amounting to $25,100, and 18 calls, totaling $1,171,479.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $310.0 to $460.0 for Arista Networks during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Arista Networks's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Arista Networks's whale trades within a strike price range from $310.0 to $460.0 in the last 30 days. 
<h3>Arista Networks Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732562136_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$51.1</td>
<td>$48.2</td>
<td>$49.55</td>
<td>$370.00</td>
<td>$297.3K</td>
<td align="right">110</td>
<td align="right">2</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$19.8</td>
<td>$19.4</td>
<td>$19.8</td>
<td>$390.00</td>
<td>$194.0K</td>
<td align="right">545</td>
<td align="right">126</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$41.2</td>
<td>$39.9</td>
<td>$41.0</td>
<td>$400.00</td>
<td>$82.0K</td>
<td align="right">309</td>
<td align="right">25</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$64.1</td>
<td>$62.7</td>
<td>$63.4</td>
<td>$350.00</td>
<td>$63.4K</td>
<td align="right">295</td>
<td align="right">10</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$35.6</td>
<td>$34.0</td>
<td>$34.0</td>
<td>$400.00</td>
<td>$51.0K</td>
<td align="right">263</td>
<td align="right">21</td>
</tr>
</tbody>
</table>

<h3>About Arista Networks</h3>
Arista Networks is a networking equipment provider that primarily sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three quarters of its sales from North America.
After a thorough review of the options trading surrounding Arista Networks, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Arista Networks</h3>
<ul>
<li>Currently trading with a volume of 960,929, the ANET's price is down by -1.93%, now at $398.62. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 77 days.</li>
</ul>
<h3>What Analysts Are Saying About Arista Networks</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $424.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Barclays persists with their Overweight rating on Arista Networks, maintaining a target price of $495. 
&#x2A; Consistent in their evaluation, an analyst from Rosenblatt keeps a Sell rating on Arista Networks with a target price of $320. 
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Neutral rating for Arista Networks, targeting a price of $425. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on Arista Networks, maintaining a target price of $460. 
&#x2A; Reflecting concerns, an analyst from Piper Sandler lowers its rating to Neutral with a new price target of $421.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Arista Networks, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

ANET

Unpacking the Latest Options Trading Trends in Arista Networks

Deep-pocketed investors have adopted a bearish approach towards Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CMG usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Chipotle Mexican Grill. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 22% leaning bullish and 55% bearish. Among these notable options, 2 are puts, totaling $111,505, and 7 are calls, amounting to $530,228.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $35.2 to $63.0 for Chipotle Mexican Grill over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Chipotle Mexican Grill's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Chipotle Mexican Grill's significant trades, within a strike price range of $35.2 to $63.0, over the past month.
<h3>Chipotle Mexican Grill 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732562131_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$7.2</td>
<td>$7.1</td>
<td>$7.17</td>
<td>$58.00</td>
<td>$182.1K</td>
<td>2.3K</td>
<td align="right">263</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$6.4</td>
<td>$6.3</td>
<td>$6.3</td>
<td>$63.00</td>
<td>$81.9K</td>
<td>1.1K</td>
<td align="right">151</td>
</tr>
<tr>
<td>CMG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$1.45</td>
<td>$1.4</td>
<td>$1.45</td>
<td>$51.00</td>
<td>$73.9K</td>
<td>4.9K</td>
<td align="right">510</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$18.6</td>
<td>$17.6</td>
<td>$18.1</td>
<td>$55.00</td>
<td>$72.4K</td>
<td>171</td>
<td align="right">40</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$32.4</td>
<td>$30.1</td>
<td>$30.4</td>
<td>$35.20</td>
<td>$63.8K</td>
<td>37</td>
<td align="right">27</td>
</tr>
</tbody>
</table>

<h3>About Chipotle Mexican Grill</h3>
Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $9.9 billion in 2023. The Mexican concept is almost exclusively company-owned, with just two license stores opearted through a master franchise relationship with Alshaya Group in the Middle East. It had a footprint of nearly 3,440 stores at the end of 2023, heavily indexed to the United States, although it maintains a small presence in Canada, the UK, France, and Germany. Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.
After a thorough review of the options trading surrounding Chipotle Mexican Grill, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Chipotle Mexican Grill's Current Market Status</h3>
<ul>
<li>With a volume of 6,882,849, the price of CMG is up 0.39% at $62.25. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 71 days.</li>
</ul>
<h3>What The Experts Say On Chipotle Mexican Grill</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $65.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Loop Capital keeps a Hold rating on Chipotle Mexican Grill with a target price of $58. 
&#x2A; An analyst from RBC Capital downgraded its action to Outperform with a price target of $70. 
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on Chipotle Mexican Grill, which currently sits at a price target of $70. 
&#x2A; An analyst from TD Cowen has decided to maintain their Buy rating on Chipotle Mexican Grill, which currently sits at a price target of $68. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Neutral rating for Chipotle Mexican Grill, targeting a price of $60. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Chipotle Mexican Grill options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Check Out What Whales Are Doing With CMG

Editor&#8217;s note: This article has been updated to clarify that the Czech government approved a draft bill regarding cannabis cultivation rather than having legalized marijuana cultivation and possession of 50 grams as was previously reported.
The Czech government recently proposed a draft law that would reform criminal law regarding cannabis, with changes including relaxed rules on home cultivation and possession. The draft law now needs to be viewed by both chambers of Parliament.
 During a press conference, Justice Minister Pavel Blažek spoke about raising and favoring financial penalties over imprisonment for cannabis offenses.
"Our punishment system is outdated and diverging from the rest of the EU, which is obviously not good," Blažek said, <a href="https://www.echo24.cz/a/H5KfB/zpravy-vlada-schvalila-novela-trestniho-zakoniku-ministr-spravedlnosti-pavel-blazek-vezeni-konopi-tresty">reported</a> Echo24, according to translation.
Under the proposed changes, which could take months to be approved, cultivating up to three cannabis plants and possessing up to 50 grams outside the home and 25 grams inside would be legal. Cultivating four to five plants would be treated as a minor offense, but anything more than that would be considered criminal activity.
The opposition Pirate Party argued that the proposal is inadequate because allowing cultivation of several plants does not permit their harvest, as three plants could yield up to 300 grams.
"Instead of legalization and additional revenue for the budget, the government presents a botched proposal," said former Deputy Prime Minister and ex-leader of the Pirate Party Ivan Bartoš. "You can grow cannabis, but you can't harvest it. Allowing the cultivation of three cannabis plants while limiting possession to 50 grams at home is absurd. It's like being allowed to keep three hens, but if they lay more than one egg, you face a fine or jail time."
Bartoš further argued that proposal is complicating the situation for up to 600,000 medical marijuana patients. The Pirate Party plans to propose increasing the legal possession limit to 900 grams.
The government wants to implement the approved changes before the end of its term.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/10/41295350/czech-senate-approves-restrictions-on-sale-of-kratom-and-hhc-products">Czech Senate Approves Restrictions On Sale Of Kratom And HHC Products</a>
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
<h2 class="wp-block-heading">Recent Calls For Regulated Cannabis Market</h2>
The news comes several months after the governing coalition confirmed it supports cannabis cultivation, but not the establishment of a regulated marijuana market. At the same time, former National Drug Coordinator Jindřich Vobořil shared he doesn't believe that the game is over for full legalization and <a href="https://www.benzinga.com/markets/cannabis/24/08/40626067/full-cannabis-legalization-not-yet-off-the-table-in-czech-republic-some-lawmakers-want-only-home" target="_blank" rel="noreferrer noopener">continues to push for it</a>.
Meanwhile, a recent study conducted by the researchers from the Faculty of Business Economics at the University of Prague concluded that the country could be <a href="https://www.benzinga.com/markets/cannabis/24/09/40879273/this-european-country-could-lose-242m-a-year-if-it-doesnt-regulate-its-marijuana-market-study-fi" target="_blank" rel="noreferrer noopener">missing out on hundreds of millions of euros </a>annually if it doesn&#8217;t establish a regulated marijuana market. As per the report a &#8220;comprehensive model,&#8221; incorporating self-cultivation, cannabis clubs and a fully commercial market, could result in "total net social benefits of CZK 5.5 billion (218 million euros; $242 million) per year.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/11/41890759/polish-parliamentary-committee-sends-cannabis-decriminalization-petition-to-prime-minister">Polish Parliamentary Committee Sends Cannabis Decriminalization Petition To Prime Minister</a></li>
</ul>
Photo: Courtesy of JESHOOTS.com via Pexels

Czech Government Approves Draft Law That Would Legalize Cultivation Of 3 Cannabis Plants, Possession Of 50 Grams (UPDATED)

The COP29 climate summit in Baku, Azerbaijan, concluded yesterday with an agreement to provide $300 billion annually to developing nations by 2035, helping to mitigate and adapt to the impacts of <a href="https://www.benzinga.com/topic/climate-change">climate change</a>. While hailed as progress to the <a href="https://www.benzinga.com/news/global/24/11/41925800/urgency-debate-mark-cop29-as-leaders-push-for-carbon-market-rules-worry-about-trump">previous $100 billion commitment</a>, the sum fell short of the $1.3 trillion initially identified as necessary to address the crisis.
&#8220;Without more substantial financing, many vulnerable countries will remain underprepared for escalating climate challenges,&#8221;<a href="https://www.wri.org/news/statement-cop29-finance-deal-downpayment-safer-more-equitable-future"> said</a> Ani Dasgupta, CEO of the World Resources Institute.
The agreement has drawn mixed reactions. Per BBC, India<a href="https://www.bbc.com/news/articles/cd0gx4przejo"> criticized</a> the deal as a "paltry sum," while Nigeria labeled it a "joke." Delegates from the Marshall Islands expressed disappointment, describing the funding as woefully inadequate, yet acknowledged it as a starting point.
Meanwhile, wildlife conservation organization WWF expressed concern, calling the deal far below the ambition needed.
"The world has been let down by this weak climate finance deal. This is a serious blow to climate action, but it must not stall the solutions that are desperately needed around the world,"<a href="https://wwf.panda.org/wwf_news/press_releases/?12844466/COP29-outcome"> said</a> WWF Global Climate and Energy Lead and COP20 President Manuel Pulgar-Vidal.
The world remains on track for a temperature rise of 3.1°C by the century&#8217;s end. That&#8217;s far above the Paris Agreement&#8217;s goal of limiting warming to 1.5°C, according to<a href="https://news.un.org/en/story/2024/10/1156071"> recent</a> UN reports.
Under the 1992 UN Framework Convention on Climate Change, 23 developed nations and the European Union must contribute to climate finance. The agreement also encourages private investment and contributions from institutions like the World Bank to meet the funding targets. The funds will support adaptation efforts. That includes building flood-resistant infrastructure and sustainable agriculture and facilitating a transition to renewable energy in developing nations.
Additionally, the summit finalized rules for a global carbon market. This system will allow companies to offset emissions by purchasing credits linked to reforestation and renewable energy initiatives. These efforts aim to accelerate the implementation of Nationally Determined Contributions (NDCs), with countries required to update their climate action plans by February 2025.
President Joe Biden<a href="https://www.whitehouse.gov/briefing-room/statements-releases/2024/11/23/statement-from-president-joe-biden-on-conclusion-of-cop29-conference-in-baku-azerbaijan/"> called</a> the agreement "an essential step toward mobilizing funds to combat the climate crisis" while acknowledging the work ahead. However, President-elect Donald Trump's return raises doubt over the future of U.S. involvement, particularly given his previous withdrawal from the Paris Agreement.
The Brazilian city of Belém will host the next summit, COP30, in November 2025. Brazilian officials have promised a high-stakes event they call the "COP of COPs," focusing on limiting global warming to 1.5°C.
iShares Global  Clean Energy ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLN#NASDAQ">ICLN</a>) rose following the news. At 12:45 pm EST, it was trading 1.83% higher at $12.34.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42170135/its-the-most-wonderful-time-of-the-year-for-the-stock-market-history-says">&#8216;It&#8217;s The Most Wonderful Time Of The Year&#8217; For The Stock Market, History Says</a></li>
</ul>
Image: Shutterstock

Global

iShares S&P Global Clean Energy Index Fund

ICLN

$300 Billion 'Joke': COP29 Reps Scoff At 'Paltry Sum' For Climate Change

<a href="https://www.wsj.com/livecoverage/stock-market-today-dow-sp500-nasdaq-live-11-25-2024/card/exclusive-starbucks-wrestles-with-ransomware-attack-on-software-supplier-cZJuRHR4rUCg8rOc9LJQ" title="https://www.wsj.com/livecoverage/stock-market-today-dow-sp500-nasdaq-live-11-25-2024/card/exclusive-starbucks-wrestles-with-ransomware-attack-on-software-supplier-cZJuRHR4rUCg8rOc9LJQ">https://www.wsj.com/livecoverage/stock-market-today-dow-sp500-nasdaq-live-11-25-2024/card/exclusive-starbucks-wrestles-with-ransomware-attack-on-software-supplier-cZJuRHR4rUCg8rOc9LJQ</a>

SBUX

Starbucks Wrestles With Ransomware Attack On Software Supplier Blue Yonder, Disrupting Employee Scheduling And Pay Tracking While Ensuring Baristas Receive Full Compensation For Hours Worked

Sony Group Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) is reportedly preparing to introduce black versions of its DualSense Edge controller, Pulse Elite wireless headphones and Pulse Explore <a href="https://www.benzinga.com/general/gaming">wireless earbuds. </a>
The news comes from renowned leaker billbil-kun <a href="https://www.dealabs.com/magazine/ces-accessoires-ps5-sortiront-bientot-dans-un-tout-nouveau-coloris-59696">via</a> Dealabs, who suggested the announcement could arrive in time for PlayStation&#8217;s 30th anniversary celebrations in December.
See Also: <a href="https://www.benzinga.com/general/gaming/24/11/42098642/play-ps5-games-without-a-console-playstation-portal-adds-cloud-streaming">Play PS5 Games Without A Console: PlayStation Portal Adds Cloud Streaming</a>
<h1 class="wp-block-heading">Familiar Prices, Bold New Look</h1>
According to billbil-kun, the black variants will be priced identically to their current white counterparts:
<ul>
<li>DualSense Edge controller: $199.99 / 239.99 euros / 209.99 pounds</li>
<li>Pulse Elite headphones: $149.99 / 149.99 euros / 129.99 pounds</li>
<li>Pulse Explore earbuds: $199.99 / 219.99 euros / 199.99 pounds</li>
</ul>
This consistency in pricing provides a compelling alternative for those who prefer a darker aesthetic without compromising on cost.
<h1 class="wp-block-heading">A Nod To PlayStation's Milestone</h1>
The timing of this rumored release aligns perfectly with Sony&#8217;s <a href="https://www.benzinga.com/general/gaming/24/09/41055245/ps5-30th-anniversary-chaos-scalpers-sweep-up-stock-leaving-fans-empty-handed">ongoing 30th-anniversary celebrations</a>, which have already included the unveiling of limited-edition PS5 consoles. A potential announcement on Dec. 3, the official anniversary date, could add to the festivities.
PlayStation has historically celebrated its milestones with special product launches, and these black accessories would continue that tradition. They also mark a shift from the white-dominated palette introduced with the PS5, giving fans more personalization options for their gaming setups.
In related news, Sony is said to be in the early stages of developing a <a href="https://www.benzinga.com/24/11/42161830/sony-eyes-portable-gaming-market-with-new-handheld-console-in-development">portable PlayStation 5.</a> 
This development aligns with the growing trend of portable gaming, spurred by competitors like the Nintendo Switch and Steam Deck.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/gaming/24/11/42169267/how-baldurs-gate-3-turned-larian-studios-into-a-447-million-powerhouse">How Baldur&#8217;s Gate 3 Turned Larian Studios Into A $447 Million Powerhouse</a></li>
</ul>

Gaming

General

Sony Group Corporation American Depositary Shares

SONY

Black PlayStation Accessories May Appear Ahead Of Holiday Season: Dealabs

<a href="https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_11252024_IMNN_Bautz.pdf" title="https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_11252024_IMNN_Bautz.pdf">https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_11252024_IMNN_Bautz.pdf</a>

Analyst Ratings

IMNN

Watching Imunon; Zacks Small-Cap Research Gives Stock $8 Price Valuation

B. Riley analyst Mayank Mamtani raised the firm's price target on Madrigal Pharmaceuticals (MDGL) to $236 from $194 and keeps a Neutral rating on t...

Madrigal Pharmaceuticals price target raised to $236 from $194 at B. Riley

Sagimet draws buy at UBS on MASH opportunity

Paulson & Co. exits AngloGold Ashanti, boosts Madrigal Pharma among Q3 moves

John Paulson's Paulson & Co. disclosed last night in an SEC filing its holdings as of September 30, 2024. Paulson's one new buy during the third qu...

Paulson takes new stake in Southwestern Energy, exits AngloGold Ashanti

Madrigal Pharmaceuticals gains amid takeover speculation

In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Madrigal Pharmaceuticals (MDGL – Research Report), with a price tar...

Madrigal Pharmaceuticals (MDGL) Receives a Buy from TD Cowen

Trump Media saw the largest increase in short interest in October

Oppenheimer analyst Jay Olson raised the firm's price target on Madrigal Pharmaceuticals (MDGL) to $400 from $350 and keeps an Outperform rating on...

Madrigal Pharmaceuticals price target raised to $400 from $350 at Oppenheimer

Novo semaglutide data in MASH could negatively impact Madrigal's Rezdiffra

The launch of Madrigal Pharmaceuticals Inc.'s NASH drug Rezdiffra exceeded all expectations in the recent quarterly earnings release. The stock rose more than 50% in a few days – and the company now has a market cap of close to $8 billion.

MDGL: A Promising Play In The Weight Loss Drug Space

AMKR

AMTM

ATUS

BIRK

CART

CELH

CORT

DOCU

ENPH

ENSG

FOUR

LCID

LINE

MDGL

NTRA

ODFL

OLLI

RIVN

SGMT

SIRI

SMMT

SWKS

UPST

VERX

VRNS

Press Releases

Madrigal Pharmaceuticals Reports Second-Quarter 2024 Financial Results and Provides Corporate Updates

Madrigal Pharmaceuticals, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Health Care

Madrigal Pharmaceuticals Announces Publication of Positive Health-Related Quality of Life Results from the Phase 3 MAESTRO-NASH Trial of Rezdiffra™ (resmetirom)

Madrigal Pharmaceuticals Appoints Dr. Michael R. Charlton as Senior Vice President, Clinical Development

Madrigal Pharmaceuticals to Participate in the H.C. Wainwright & Co. 8th Annual MASH Investor Conference

Madrigal Pharmaceuticals to Release Third-Quarter 2024 Financial Results and Host Webcast on October 31, 2024

Madrigal Pharmaceuticals Completes Enrollment of Clinical Outcomes Study of Resmetirom in Patients with Compensated NASH/MASH Cirrhosis

Madrigal Pharmaceuticals to Present Multiple Rezdiffra™ (resmetirom) Abstracts in NASH/MASH at the AASLD Liver Meeting®

Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates

Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences

Comments

Madrigal Pharmaceuticals

空売り

Madrigal Pharmaceuticals (NASDAQ:MDGL) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル